FDA Approves First Oral Antiviral for Treatment of COVID-19 in Adults

The FDA approved oral antiviral Paxlovid for the treatment of mild-to-moderate COVID-19 in adults who are at high risk for progression to severe COVID-19, including hospitalization or death.